Gene · 6314
Papers1,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7. | Stem Cell Res | 2024 | 38851031 | PubTator, text mining | PubMed |
| CAG repeat mosaicism is gene specific in spinocerebellar ataxias. | Am J Hum Genet | 2024 | 38626762 | PubTator, text mining | PubMed |
| Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG-PET presentation in spinocerebellar ataxia 17: a case report. | Neurol Sci | 2024 | 38494459 | PubTator, text mining | PubMed |
| ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study. | JAMA Ophthalmol | 2024 | 38421662 | PubTator, text mining | PubMed |
| Retinal End Points for ATXN7-Related Spinocerebellar Ataxia. | JAMA Ophthalmol | 2024 | 38421660 | PubTator, text mining | PubMed |
| RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci. | Genome Biol | 2024 | 38297326 | PubTator, text mining | PubMed |
| Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia. | Mov Disord Clin Pract | 2024 | 38291845 | PubTator, text mining | PubMed |
| LUSTR: a new customizable tool for calling genome-wide germline and somatic short tandem repeat variants. | BMC Genomics | 2024 | 38279154 | PubTator, text mining | PubMed |
| Reanalysis of Trio Whole-Genome Sequencing Data Doubles the Yield in Autism Spectrum Disorder: De Novo Variants Present in Half. | Int J Mol Sci | 2024 | 38256266 | PubTator, text mining | PubMed |
| Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations. | BMC Med Genomics | 2024 | 38254109 | PubTator, text mining | PubMed |
| On the Cut-Off Value of the Anteroposterior Diameter of the Midbrain Atrophy in Spinocerebellar Ataxia Type 2 Patients. | Brain Sci | 2024 | 38248268 | PubTator, text mining | PubMed |
| Longitudinal MRI and 1H-MRS study of SCA7 mouse forebrain reveals progressive multiregional atrophy and early brain metabolite changes indicating early neuronal and glial dysfunction. | PLoS One | 2024 | 38227598 | PubTator, text mining | PubMed |
| Early-onset familial essential tremor is associated with nucleotide expansions of spinocerebellar ataxia in China. | Mol Biol Rep | 2024 | 38227102 | PubTator, text mining | PubMed |
| Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. | Nat Commun | 2024 | 38216551 | PubTator, text mining | PubMed |
| The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias. | Cerebellum | 2024 | 38165578 | PubTator, text mining | PubMed |
| Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. | EBioMedicine | 2024 | 38150853 | PubTator, text mining | PubMed |
| Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan. | Ann Clin Transl Neurol | 2024 | 37916889 | PubTator, text mining | PubMed |
| Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics. | Neural Regen Res | 2024 | 37862191 | PubTator, text mining | PubMed |
| Dilemma in differentiation of spinocerebellar ataxia type 17 from Huntington's disease: comorbidity or independent disease? | Int J Neurosci | 2024 | 37855597 | PubTator, text mining | PubMed |
| Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan. | J Hum Genet | 2024 | 37848721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6314/papers?page=4